ThinkEquity Starts Cell Therapeutics (CTIC) at Buy
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 18 | New: 11
Rating Summary:
10 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 18 | New: 11
Join SI Premium – FREE
ThinkEquity initiates coverage on Cell Therapeutics (NASDAQ: CTIC) with a Buy. PT $3.00.
For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.
Shares of Cell Therapeutics closed at $1.46 yesterday.
For an analyst ratings summary and ratings history on Cell Therapeutics click here. For more ratings news on Cell Therapeutics click here.
Shares of Cell Therapeutics closed at $1.46 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Canada Starts Apotex Health Corp (APTX:CN) at Buy
- Jefferies Starts Apotex Health Corp (APTX:CN) at Buy
- Barclays Starts Forbright Inc (FRBT) at Overweight
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
ThinkEquitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
